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Mood, anxiety, and other psychological symptoms are common in dystonic patients
suffering from blepharospasm (BSP) and spasmodic torticollis (ST). Since sexual well-
being is an important aspect of mental health, here, we investigated whether these
patients may also experience a worsening of their sexual life. In particular, quality of
sexual life was evaluated in patients suffering from BSP (N = 30), ST (N = 30), and in
a control group of patient with Hemifacial spasm (HFS; N = 30), undergoing botulinum
toxin type A therapy. A group of 30 age-matched healthy volunteers constituted an
additional control group. Patients were evaluated just before the periodic injection
of botulinum toxin. Sexual functioning was assessed using the Sexual Functioning
Inventory, a reduced form of the Golombok Rust Inventory, previously employed
in patients with Parkinson’s disease. Depression (Beck Depression Inventory) and
anxiety (STAI-X1/X2) were also assessed. Results revealed that sexual functioning was
significantly affected in patients with BSP, ST, and HFS with respect to healthy controls.
Dystonic patients manifested more sexual dysfunction than patients with HFS. Overall,
females had a poorer quality of sexual life than males and, among females, women with
BSP were the most dysfunctional. Psychological symptoms were present in patients
with dystonia, but not in patients with HFS. As discussed in the paper, several factors
might be taken into account to explain worse quality of sexual life in patients with
dystonia compared to patients with hemifacial spasm. Among them an important role
might be played by the central origin of dystonia pathophysiology (i.e., altered activity of
cortico-striato-thalamic-cortical circuits). Future investigations are necessary to further
explore these preliminary findings, considering that this is the first time that sexual well-
being is evaluated in patients with BSP, ST, and HFS, and comparable data are not
available.
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INTRODUCTION
Dystonia is a neurological movement disorder in which sustained
or intermittent muscle contractions result in abnormal, often
repetitive movements, and/or postures. Blepharospasm (BSP)
and spasmodic torticollis (ST) are two of the most common
forms of dystonia (Albanese et al., 2013). BSP is a focal dystonia
characterized by bilateral involuntary contraction of orbicularis
oculi muscles with the consequence of continuous or intermittent
forceful closure of the eyelids (Dashtipour et al., 2015). Neural
circuits underlying the pathophysiology of BSP involve the basal
ganglia, the thalamus, and the peduncle-mesencephalic area
(Defazio et al., 2007). ST is the most common form of idiopathic
focal dystonia and is characterized by intermittent or sustained
deviation of the neck, accompanied by pain. The pathophysiology
of ST seems to specifically involve the basal ganglia and their
connections to cortical areas (Jinnah et al., 2013; Avanzino and
Fiorio, 2014).
Recent studies report the presence of mood, anxiety, and
other psychological symptoms in patients with BSP and ST, and
suggest that successful local treatment of movement disorders,
typically done with botulinum toxin therapy (BoNTA), is not
necessarily linked to patients’ improvement in social ability and
emotional state (Tucha et al., 2001; Reimer et al., 2005; Hall
et al., 2006; Slawek et al., 2007; Setthawatcharawanich et al., 2011;
Stamelou et al., 2012; Berardelli et al., 2015). In these studies,
BSP is very often compared to Hemifacial spasm (HFS), that,
by being a peripherally induced movement disorder, might be
considered a natural control condition. HFS is characterized by
clonic-tonic contractions of the orbicularis oculi muscles, usually
of one-half of the face, and is typically caused by facial nerve
irritation due to a neurovascular conflict (Wang and Jankovic,
1998). Despite improvement of dystonic manifestations due to
the treatment, patients with BSP show higher levels of depression,
anxiety, and obsessive-compulsive symptoms and, in general,
a worse quality of life, than patients with HFS (Scheidt et al.,
1996; Broocks et al., 1998; Tucha et al., 2001; Tan et al., 2005,
2006; Hall et al., 2006; Barahona-Corrêa et al., 2011; Fontenelle
et al., 2011; Setthawatcharawanich et al., 2011; Lehn et al., 2014).
Nonetheless, few authors do not report differences in obsessive-
compulsive symptoms between the two diseases (Hall et al.,
2005; Munhoz et al., 2005; Fontenelle et al., 2011). The findings
of worse psychological symptoms in BSP than HFS might be
related to the presence of more severe visual impairment and
ophthalmological pain (Martino et al., 2005) with consequences
on everyday life (Reimer et al., 2005; Hall et al., 2006). However,
it might also be ascribed to dysfunction of the cortico-subcortical
circuits (i.e., cortico-striatal circuitry comprising fronto-orbital
and cingulate structures) that are typically involved in mood
disorders (Broocks et al., 1998; Munhoz et al., 2005; Reimer
et al., 2005; Barahona-Corrêa et al., 2011; Conte et al., 2016).
Studies investigating psychological variables in patients with ST,
undergoing BoNTA treatment, report that the most common
psychological symptoms manifested by these patients are anxiety
(Wenzel et al., 1998; Gündel et al., 2003), depression (Jahanshahi
and Marsden, 1988; Pekmezovic et al., 2009; Fabbrini et al., 2010),
and social embarrassment accompanied by social avoidance
(Jahanshahi, 1991; Comella and Bhatia, 2015). One study (Gündel
et al., 2001), evaluating 116 patients with ST, shows that
more than 50% of them fulfilled modified DSM-IV criteria for
social phobia, independently of the severity of the disorder.
Moreover, some authors consider depression a consequence of
postural abnormalities (Jahanshahi and Marsden, 1990, 1992),
while others as an independent factor (Stamelou et al., 2012)
and the main predictor of worse quality of life (Slawek et al.,
2007). An interesting study reports that the majority of ST
patients perceived some or severe stigma mainly due to physical
disfigurement (Papathanasiou et al., 2001).
Thus, there is evidence of mood, anxiety, and other
psychological symptoms in patients with BSP and ST, undergoing
BoNTA treatment, but none of the above studies has investigated
whether these patients may also experience a worsening of their
sexual life. Since sexual functioning is an important aspect of
mental health (World Association for Sexual Health [WAS],
2008), and it has been found to be deficient in neurological
patients with other types of movement disorders (such as, for
example Parkinson’s disease, Castelli et al., 2004), in the current
study, we investigated whether dystonic patients with BSP and
ST may also experience a worsening of their sexual life. We
also explored the putative relationship of this aspect of mental
health with other psychological factors often aﬄicting patients
with dystonia.
To these aims, we assessed the presence of psychological
symptoms (i.e., anxiety and depression) and of sexual dysfunction
in male and female patients with BSP and ST and in a
control group of patients with HFS. Another control group was
constituted by age-matched healthy controls. Sexual functioning
was evaluated through the Sexual Functioning Inventory (SFI),
a tool that proved to be sensitive in the assessment of sexual
dysfunction in neurological patients with Parkinson’s disease
(Castelli et al., 2004). The existence of possible correlations
between sexual functioning, the above psychological aspects, or
gender and age was also evaluated.
On the basis of previous findings, we expected to observe more
severe psychological symptoms in patients with dystonia (BSP
and ST) than in patients with HFS. In addition, we predicted
that if a relationship existed between psychological symptoms
and sexual functioning, then worse quality of sexual life might
also be expected in patients with dystonia compared to patients
with HFS.
MATERIALS AND METHODS
Participants
Ninety patients were submitted to a psychological assessment,
at the San Giovanni Battista Hospital in Turin, Italy, before
undergoing the periodic injection of botulinum toxin type A
(BoNTA) therapy. Thirty of them were affected by BSP, 30
suffered from ST and 30 manifested HFS. In order to assess
sexual well-being in patients with homogeneous and stable
clinical conditions, only chronic patients (duration of illness
ranged from 12 to 15 years), undergoing the BoNTA treatment
for at least 8 years (the duration of the BoNTA treatment
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ranged from 8 to 11 years) were enrolled in the study. Most
importantly, only patients with a moderate (grade 3: functional
impairment) disability (Jankovic et al., 1990) were included in the
study. The exclusion criteria from the study were the presence
of dementia, psychiatric disease such as Psychosis or Major
Depression, motor disorder like Parkinson’s disease or other
type of comorbidities and the presence of autonomic urogenital
dysfunction on interview or physical examination. None of the
patients had history of alcohol or drug abuse.
A healthy control group of 30 participants was matched
to patients for sex, age, and educational level. Patients and
control participants were all heterosexual. In Table 1 are reported
demographic and clinical data for each group of participants.
The study was carried out in accordance with the
recommendations of the Declaration of Helsinki. Participants
were given a detailed explanation of the study and an informed
consent, previously approved by the Local Ethical Committee of
the hospital, was obtained from all individuals included in the
study.
Psychological Assessment
Depression was evaluated using the Beck Depression Inventory
(BDI; Beck, 1987), a 21-item self-rating scale investigating
cognitive, behavioral, and somatic aspects of depression.
Anxiety was assessed using the State-Trait Anxiety Inventory
(STAI; Spielberg et al., 1980), a 40-item self-rating scale assessing
anxiety as a reaction to episodic stress condition (STAI-X1) or as
a general predisposition for anxious behavior (STAI-X2).
Sexual Function Assessment
Sexual well-being was evaluated using the SFI (Castelli et al.,
2004), a reduced form of the Golombok-Rust Inventory of Sexual
Satisfaction (Rust and Golombok, 1986). SFI is a 15-item self-
rating scale investigating seven sexual disorders: infrequency,
non-communication, dissatisfaction, avoidance, non-sensuality,
premature ejaculation-vaginismus, and impotence-anorgasmia.
Two different forms of the questionnaire were used for men
and women. The score ranges from 15 to 60 with higher scores
indexing greater sexual dysfunction.
Statistical Analysis
Differences between the three groups of patients and controls
on SFI total score and each subscale were analyzed by means
of ANOVAs with GROUP (BSP, HFS, ST, and Controls) and
TABLE 1 | Demographic and clinical characteristics.
Group Sex Age Education
Blepharospasm (BSP) M (15) 66.20 (4.46) 5.93 (2.52)
F (15) 66.33 (10.51) 6.60 (1.55)
Hemifacial spasm (HFS) M (15) 64.00 (11.59) 8.07 (3.01)
F (15) 67.33 (6.04) 7.73 (3.33)
Spasmodic torticollis (ST) M (15) 61.53 (8.63) 8.73 (2.91)
F (15) 67.77 (6.44) 7.40 (2.67)
Controls M (15) 63.27 (2.12) 7.47 (2.67)
F (15) 63.20 (2.14) 7.53 (2.67)
GENDER (Males and Females) as between-subjects factors. Data
analysis was also performed including the BDI and the STAI as
covariates (ANCOVA) in order to evaluate their role on sexual
well-being.
Differences between the three groups of patients and controls
on the BDI, STAI-X1, and STAI-X2, were also investigated by
means of ANOVAs with GROUP (BSP, HFS, ST, and Controls)
and GENDER as between-subjects factors. Post hoc comparisons
were performed using Tuckey’s HSD procedure.
The Pearson correlation coefficient was employed to assess
correlations between sexual functioning scores, psychological
tests, and socio-demographic variables (age and education) in
patients.
RESULTS
No significant differences were found among the three groups of
patients with respect to clinical and demographic characteristics.
Patients did not differ from controls in demographic variables
(age and education).
Psychological Scales
Significant differences between patients and controls and among
the groups of patients were found on the psychological scales
(Table 2). The ANOVAs revealed a main effect of the factor
GROUP for BDI [F(3,112) = 9.845, p < 0.001, η2p = 0.209],
STAI-X1 [F(3,112) = 10.476, p < 0.001, η2p = 0.219], STAI-
X2 [F(3,112) = 10.702, p < 0.001, η2p = 0.223]. Tuckey’s HSD
tests showed that patients with BSP and ST had significantly
higher scores than patients with HFS and healthy participants on
BDI, STAI-X1, and STAI-X2 (p < 0.006 for each comparisons).
Moreover, HFS patients did not show any significant difference
with healthy participants on these scales. To summarize, dystonic
patients with BSP and ST scored worse on the psychological scales
than patients with HFS. In addition, these patients had scores not
significantly different from those of healthy individuals.
Sexual Functioning
Table 3 reports mean and standard deviations of the SFI scores
for patients and controls.
On the total SFI score, the ANOVA revealed significant
main effects of GROUP [F(3,112) = 12.524, p < 0.0001,
η2p = 0.251] and GENDER [F(1,112) = 21.139, p < 0.001,
η2p = 0.159]. Tuckey’s HSD tests showed that BSP, HFS, and
ST patients had a total SFI score significantly higher than
healthy participants (p< 0.004 for each comparisons). Moreover,
females had higher scores than males. Thus, on this test, the
three groups of patients showed worse sexual functioning than
healthy matched controls, and overall women scored worse
than men. The ANOVAs performed on each subscale revealed
that the main factor GROUP was significant for the following
item: infrequency [F(3,112) = 8.237, p < 0.0001, η2p = 0.181],
dissatisfaction [F(3,112) = 6.759, p < 0.001, η2p = 0.153],
non-sensuality [F(3,112) = 3.997, p < 0.01, η2p = 0.097],
premature ejaculation-vaginismus [F(3,112) = 4.131, p < 0.01,
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TABLE 2 | Results of BDI, STAI-X1, and STAI-X2.
BSP HFS ST C
Beck Depression Inventory (BDI) 11.03 (6.24) 6.43 (3.14) 11.17 (7.88) 5.50 (0.86)
State-Trait Anxiety Inventory (STAI)-X1 41.17 (8.42) 34.97 (4.4) 40.07 (9.77) 32.63 (2.20)
STAI-X2 41.20 (7.12) 33.83 (5.94) 41.00 (10.79) 33.53 (2.73)
TABLE 3 | Sexual Functioning Inventory (SFI) results.
BSP HFS ST Controls
Infrequency 6.33 (0.84) 5.77 (1.28) 6.27 (1.08) 5.23 (0.73)
Non-communication 5.03 (1.83) 5.07 (1.72) 5.20 (1.32) 4.23 (1.19)
Dissatisfaction 6.40 (1.30) 5.77 (1.57) 6.10 (1.54) 4.93 (0.87)
Avoidance 4.17 (1.44) 3.87 (1.22) 4.17 (1.26) 3.47 (1.25)
Non-sensuality 2.83 (0.91) 2.77 (1.04) 3.10 (1.40) 2.20 (0.61)
Premature ejaculation/Vaginismus 2.77 (0.82) 2.47 (1.01) 2.37 (0.96) 2.00 (0.74)
Impotence/Anorgasmia 2.13 (1.07) 1.93 (0.91) 2.03 (0.56) 1.37 (0.56)
Total score 31.80 (5.01) 29.60 (6.23) 31.30 (4.17) 25.63 (3.09)
η2p = 0.100], and impotence-anorgasmia [F(3,112) = 7.689,
p < 0.0001, η2p = 0.171]. According to post hoc analyses,
BSP and ST patients had higher scores than controls on the
infrequency and dissatisfaction subscales, while HFS patients
did not differ from controls on these subscales (p < 0.006
for each comparisons). In addition, BSP patients had higher
scores than controls on the premature ejaculation-vaginismus
subscale and ST patients on the non-sensuality subscale
(p < 0.007 for each comparisons). The three groups of patients
showed more disorders of impotence-anorgasmia than controls
(p < 0.007 for each comparisons). The ANOVAs also revealed a
significant main effect of GENDER on the following subscales:
infrequency [F(1,112) = 7.875, p < 0.01, η2p = 0.066], non-
communication [F(1,112) = 18.370, p < 0.001, η2p = 0.141],
avoidance [F(1,112) = 49.790, p < 0.0001, η2p = 0.308],
premature ejaculation-vaginismus [F(1,112)= 13.266, p< 0.001,
η2p = 0.106], and impotence-anorgasmia [F(1,112) = 41.782,
p < 0.001, η2p = 0.272]. Females had higher scores than
males on all the above subscales except for the premature
ejaculation-vaginismus item, where men scored worse than
women (Table 4). These findings were not affected by the
inclusion of BDI and STAI as covariates in the analyses,
suggesting that these variables did not affect the above
results.
A significant interaction GROUP X GENDER was found on
the impotence-anorgasmia subscale [F(3,112) = 3.337, p < 0.05,
η2p = 0.082]. Tuckey’s HSD tests showed that BSP females had
a significantly higher score (M = 2.87, SD = 0.99) than BSP
males (M = 1.40, SD = 0.51), ST males (M = 1.73, SD = 0.46),
HFS males (M = 1.60, SD = 0.83), control males (M = 1.13,
SD= 0.35), and control females (M = 1.60, SD= 0.63; p< 0.001
for each comparisons); ST females had significantly higher score
(M = 2.33, SD = 0.49) than BSP males and control males
(p ≤ 0.01 for each comparisons); similarly, HFS females had
significantly higher score (M = 2.27, SD = 0.88) than BSP males
and control males (p< 0.007 for each comparisons).
TABLE 4 | Results of the SFI for females and males.
Male Female
Infrequency 5.65 (1.19) 5.65 (1.19)
Non-communication 4.32 (1.35) 5.45 (1.58)
Dissatisfaction 5.68 (1.44) 5.92 (1.44)
Avoidance 3.22 (0.74) 4.62 (1.39)
Non-sensuality 2.77 (1.16) 2.68 (0.98)
Premature ejaculation/Vaginismus 2.68 (0.85) 2.12 (0.90)
Impotence/Anorgasmia 1.47 (0.60) 2.27 (0.88)
Total score 27.77 (4.60) 31.40 (5.36)
Correlations
Pearson analyses revealed that BDI positively correlated with
the SFI total score (r = 0.238, p = 0.024), and the infrequency
subscale (r = 0.287, p = 0.006). STAI-X1 (r = 0.306, p = 0.003)
and STAI-X2 (r = 0.320, p = 0.002) scores positively correlated
with infrequency subscale.
Positive correlations were also found between age and total
SFI score (r = 0.293, p = 0.005), infrequency (r = 0.296,
p = 0.005), non-communication (r = 0.320, p = 0.002),
premature ejaculation-vaginismus (r = 0.232, p = 0.028), and
impotence-anorgasmia (r = 0.318, p= 0.002) subscales.
DISCUSSION
There is evidence of mood and anxiety symptoms in dystonic
patients with blepharospasm and (ST) undergoing BoNTA
therapy, but no data are available on their sexual well-
being. Here, we assessed these patients’ sexual functioning
and its putative relationship with other aspects of mental
health (i.e., depression and/or anxiety). To this aim, patients
with a peripherally induced movement disorder, i.e., HFS,
and age-matched healthy volunteers constituted the control
groups.
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The results of the present study showed the presence of
depressive and anxious symptoms in patients with BSP and
ST, but not in patients with HFS. Overall, these findings are
in line with the evidence of higher levels of depression and
anxiety, obsessive compulsive, and social phobia symptoms,
associated with poorer quality of life in BSP and ST compared
to HFS patients (Bihari et al., 1992; Hall et al., 2006; Tan et al.,
2006; Pekmezovic et al., 2009; Barahona-Corrêa et al., 2011;
Fontenelle et al., 2011; Setthawatcharawanich et al., 2011; Lehn
et al., 2014). Most importantly, although sexual functioning
was affected in all groups of patients (i.e., higher incidence
of impotence in men and anorgasmia in women), dystonic
patients were the most compromised. Men and women with BSP
reported additional physiological dysfunctions (i.e., premature
ejaculation and vaginismus, respectively), that likely affected the
frequency of intercourse events. Infrequency of intercourse was
also reported by ST patients, who also showed lower scores on
non-sensuality (i.e., enjoying cuddling and caressing) subscale.
This latter outcome might be related to embarrassment caused by
postural abnormalities and perception of physical disfigurement.
The degree of sexual dysfunction of the two groups of dystonic
patients was reflected in their level of dissatisfaction: both groups
were not satisfied with their sexual life, while HFS patients
reported the same level of satisfaction as healthy controls.
Finally, all groups of patients had normal scores on the sexual
avoidance subscale, suggesting that interpersonal and emotional
aspects of sexual life were overall preserved, especially in
patients whose movement disorders were confined to craniofacial
muscles.
Besides the type of neurological disease, another factor
affecting sexual functioning was gender. Overall women had a
poorer quality of sexual life than men in relation to several
psychological components (i.e., frequency of intercourse events,
communication, and avoidance) and one physiological aspect
(i.e., on the impotence/anorgasmia item). Men scored worse
than women only on the premature ejaculation-vaginismus item.
Overall, women with BSP resulted to be the most compromised
on the anorgasmia item.
Correlation analyses showed that depression as well as
age were positively related to sexual dysfunction (i.e., total
SFI score). Indeed, both factors are crucial determinants of
sexual well-being (Lipe et al., 1990; Welsh et al., 1997; Moore
et al., 2002; Bronner et al., 2014). Importantly, our findings
revealed that higher levels of depression and anxiety were
specifically related to less frequent intercourse events. On the
other hand, age correlated with the number of physiological
dysfunctions, and negatively affected the frequency of intercourse
and communication on sexual life. These results are in line
with previous findings (Gott and Hinchliff, 2003; Ni Lochlainn
and Kenny, 2013) showing that worsening of sexual life with
age is especially due to physiological factors and difficulties
in talking about sexual issues with the partner and/or the
specialist.
Since, to our knowledge, this is the first study on sexual
well-being in BSP, ST, and HFS patients, comparable data
are not available. However, our findings are consistent with
previous evidence showing sexual dysfunction in patients
affected by another type of movement disorder, i.e., Parkinson’s
disease (Lambert and Waters, 1998; Bronner et al., 2014),
and its improvement, following deep brain stimulation of the
subthalamic nucleus, in men but not in women (Castelli et al.,
2004). Moreover, they are in line with the evidence that quality
of life is poorer in women than in men with BSP (Müller et al.,
2002).
To summarize, our findings show the presence of depressive
and anxiety symptoms and worse quality of sexual life in patients
with dystonia compared to patients with HFS and age-matched
healthy subjects. This outcome and the presence of positive
correlation between depression/anxiety and sexual dysfunction
suggest that psychological symptoms and sexual well-being might
be related in these patients. Several factors might be taken
into account to explain more severe psychological symptoms
in dystonic patients. Some authors underline the presence of
severe visual impairment, ophthalmological pain, and driving
difficulty in BSP (Martino et al., 2005; Reimer et al., 2005; Hall
et al., 2006). Pain is an important variable that significantly
affects general well-being also in ST (Chan et al., 1991; Slawek
et al., 2007; Comella and Bhatia, 2015), and neck pain is a
main determinant of depression in these patients (Müller et al.,
2002). Another aspect, that might account for psychological
symptoms in dystonic patients is self-consciousness of the altered
physical appearance. A previous study (Papathanasiou et al.,
2001) underlines that social stigma in ST patients, mainly
related to physical appearance, negatively affects interpersonal
relationships and, we hypothesize, sexual well-being too. Other
authors (Jahanshahi and Marsden, 1990) found that negative
body image has an important impact on depression and
psychological well-being in ST. Besides pain and negative
body concept due to disfigurement, psychological symptoms
might be, at least in part, related to the pathophysiology
of dystonic syndromes. Indeed, dysfunction of cortico-basal
ganglia circuits may be associated with mood and anxiety
disorders (Marchand, 2010). In addition, the central origin of
dystonia pathophysiology, i.e., altered activity of cortico-striato-
thalamic-cortical circuits (Quartarone and Hallett, 2013), might
also have a role in sexual dysfunction. On the one hand,
reduction of striatal dopamine leads to disinhibition of fronto-
orbital and cingulate cortices, that are involved in regulation of
motivation and emotion. On the other hand, chronic anxiety
might induce a dysfunctional state of hypocortisolism and
further reduce dopamine levels in the striatum (Pruessner
et al., 2004; Hall et al., 2005; Defazio et al., 2007; Barahona-
Corrêa et al., 2011), that have a key role in both sexual
arousal and desire (Giuliano and Allard, 2001; Brom et al.,
2014).
Despite sexual well-being might be a consequence of
psychological factors and/or altered activity of cortico-subcortical
circuits, the correlational nature of our data do not allow to
draw conclusions about the causal role of the above factors on
sexual dysfunction. Another limitation of the current study is
the absence of a measure of the patients’ global quality of life.
Because of outpatients’ time constraints, we had to employed a
limited number of clinical tests. The use of additional clinical
evaluations (for example the SF-36 scale), besides SFI, BDI, and
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STAI, would have allowed to correlate our findings to other
measures of the patients well-being in order to draw clearer and
stronger conclusions. Future studies employing more extensive
clinical examination and, when possible, neurophysiological, or
neuroimaging measures of brain activity, in larger groups of
patients are, indeed, necessary to validate and further explore
these preliminary findings.
CONCLUSION
This is the first investigation highlighting an important aspect
of psychological well-being, that is seldom investigated by
clinicians in patients affected by neurological disorders. Based on
a multidimensional concept of health-related quality of life, we
are in line with other studies (Gündel et al., 2001; Müller et al.,
2002; Tan et al., 2005, 2006; Taylor and Gosney, 2011; Bronner
et al., 2014) recommending more attention to clinical symptoms
not immediately manifest, and adequate psychological support,
when necessary.
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